home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410n.zip
/
M94A2632.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
2KB
|
39 lines
Document 2632
DOCN M94A2632
TI Title: Papanicolaou (PAP) smears versus colposcopy as screening tests
for cervical intraepithelial neoplasia (CIN) in HIV seropositive women.
DT 9412
AU Norton D; Brosgart C; Barkin M; Zaloudek C; Palefsky J; Padian N;
Greenblatt R; East Bay AIDS Center, Berkeley, CA 94705.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):26 (abstract no. 079B). Unique
Identifier : AIDSLINE ICA10/94369943
AB OBJECTIVE: To compare the results of pap smears versus colposcopy as a
screening test for cervical intraepithelial neoplasia (CIN) in HIV
seropositive women. METHODS: Sample 100 HIV positive and 50 HIV negative
women, pregnant women excluded. Between 4/93 and 2/94, 76 HIV positive
and 20 HIV negative women enrolled. Exam includes consent, complete
history and physical exam. CD4, pelvic exam with pap smear and
colposcopy, screening tests for STD's (HIV, HPV, RPR, chlamydia,
candida, bacteria and trichomonas), and directed cervical biopsies as
indicated, are performed at enrollment, 6 months and 12 months. At study
completion, all HIV positive women will be offered enrollment in a
long-term natural history study of women with HIV disease. FINDINGS: 40%
of HIV positive women have abnormal pap smears at entry compared to 10%
of controls; 37% of HIV positive women had abnormal Colposcopic exams
compared to 10% of controls. 59% of Negative pap smears in HIV positive
women are positive for oncogenic types of HPV. 60% of women with
negative pap smears are positive for HPV. CONCLUSIONS: There is good
correlation between the results of pap smear as compared to colposcopy
in screening for CIN in HIV positive women. At study completion, data
will be available in regards to the recommended frequency of cervical
screening on HIV positive women (6 versus 12 months).
DE Carcinoma in Situ/COMPLICATIONS/*DIAGNOSIS Cervix
Neoplasms/COMPLICATIONS/*DIAGNOSIS Cervix Uteri/MICROBIOLOGY
*Colposcopy Comparative Study Female Human HIV Seronegativity HIV
Seropositivity/*COMPLICATIONS Papillomavirus, Human/ISOLATION & PURIF
Sensitivity and Specificity *Vaginal Smears MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).